Total planned funding: $156,914,493
Allocations
Countries/Regions
India | $156,914,493 |
Organizational Types
Unknown | $76,423,236 |
NGO | $38,222,060 |
Own Agency | $21,612,900 |
University | $8,390,217 |
Private Contractor | $4,098,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,466,808 |
FBO | $1,400,000 |
Host Country Government Agency | $1,201,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $70,991,183 |
Prevention | $33,840,469 |
Management and Operations | $17,784,247 |
Care | $16,081,498 |
Testing | $6,923,348 |
Treatment | $6,865,956 |
Budget Codes
OHSS: Health Systems Strengthening | $43,135,733 |
HVSI: Strategic Information | $22,658,171 |
HVMS: Management and Operations | $17,784,247 |
HVOP: Sexual Prevention: Other Sexual Prevention | $17,290,205 |
HBHC: Care: Adult Care and Support | $9,477,121 |
HVCT: Testing: HIV Testing and Counseling | $6,923,348 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,417,476 |
HTXS: Treatment: Adult Treatment | $6,374,321 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,671,815 |
HLAB: Laboratory Infrastructure | $5,197,279 |
HKID: Care: Orphans and Vulnerable Children | $3,264,038 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,161,320 |
HVTB: Care: TB/HIV | $2,808,289 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
PDCS: Care: Pediatric Care and Support | $532,050 |
PDTX: Treatment: Pediatric Treatment | $468,158 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$76,423,236
Countries/Regions
USG Aggregated Agencies:
$15,620,001
Countries/Regions
FHI 360:
$12,038,825
Countries/Regions
Voluntary Health Services:
$6,960,000
Countries/Regions